21st Century Oncology Holdings, the largest integrated network of cancer treatment centers and affiliated physicians, announced terms for its IPO on Wednesday. The Fort Myers, FL-based company plans to raise $200 million by offering 13.3 million shares at a price range of $14 to $16. At the midpoint of the proposed range, it would command a market value of $446 million. 21st Century will offer $75 million of mandatory convertible preferred stock concurrently with the offering. The company had previously traded on the NASDAQ as Radiation Therapy Services under the ticker RSTX until it was acquired by Vestar for $1.1 billion in 2008.
21st Century Oncology Holdings, which was founded in 2007, plans to list on the NYSE under the symbol ICC. It initially filed confidentially on December 10, 2013. Morgan Stanley, J.P. Morgan and Wells Fargo Securities are the joint bookrunners on the deal. It is expected to price the week of May 19, 2014.
